OAS1 and Alzheimer disease: Importantly, this study adds data to fill the mechanistic gap for the potential role for OAS1 in AD pathology, providing the first evidence that endogenous dsRNA is produced in response to Aβ oligomers and indicating that OAS1 might dimerize and facilitate RNA clearance, reducing inflammation.